Dr. Peter Thomas Galantich, MD

Dr. Galantich practices at Riverside Regional Medical Center in Newport News, Virginia, part of Riverside Health System.

Dr. Galantich's NPI, 1457321515, was assigned on January 23, 2006. Dr. Galantich graduated from New York Medical College in 1984. Dr. Galantich holds Virginia license 0101044676.

Dr. Galantich's primary practice is Riverside Regional Medical Center, at 500 J Clyde Morris Blvd, Newport News, VA 23601 in Newport News City. The practice phone is (757) 594-2000.

Dr. Galantich's primary practice is Riverside Regional Medical Center in Newport News, Virginia, part of Riverside Health System. Dr. Galantich is also affiliated with Riverside Walter Reed Hospital. The medical group on file is Riverside Gastroenterology Specialists. Dmand AI also links Dr. Galantich to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galantich practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Galantich's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Galantich is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Galantich's licenses on file in 3 states: Virginia, New Jersey and Maryland.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Galantich treats.

CMS data shows 635 Medicare services from Dr. Galantich across 6 procedure codes in 2024, for 365 Medicare patients. Medicare paid $27,004 for them. Every service was in an office.

CMS counts 365 Medicare patients who saw Dr. Galantich in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Galantich's median patient age at 65, with 60% women.

In 2024, Dr. Galantich wrote 426 Medicare Part D claims for 146 patients. 95% of them were for generic drugs. CMS names the drug for 324 of them, across 9 drugs with 11 or more claims each, at $30,995 in total drug cost. In 2023, CMS named 274 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Galantich for performance year 2024, reported through an alternative payment model (APM). Dr. Galantich accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Galantich.

CMS Open Payments shows 87 general payments to Dr. Galantich from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Inspire Medical Systems, Inc. paid the most, $1,742.

Dmand AI lists 4 awards for Dr. Galantich, most recently CMS Stage 1 2012 in 2012.

Dr. Galantich graduated from New York Medical College in 1984. Dr. Galantich is a member of NHS and ACS.

Dr. Galantich is in network with 15 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.